Literature DB >> 8647057

The cow milk allergy complex: overlapping disease profiles in infancy.

D J Hill1, C S Hosking.   

Abstract

Community based studies suggest reported reactions to cow's milk are very common in the first 12 months of life but many of them may not be reproduced on challenge. Recent laboratory based studies have identified three groups of infants with cow milk allergy (CMA) who demonstrate different symptom and laboratory profiles. The first, an IgE-sensitized group, shows features of immediate cutaneous eruptions and anaphylaxis. The second, a non-IgE sensitized group, develops gastrointestinal symptoms within hours of ingesting moderate amounts of cow milk, whereas the third group of patients shows symptoms of gastrointestinal disturbance with or without bronchitic and/or eczematous symptoms after ingesting cow milk over several hours or days. The late reacting non-IgE sensitized CMA patients demonstrate elevated T-cell reactivity in vitro to milk proteins. Hospital based studies, which are likely to reflect the more severe end of the spectrum of CMA, suggest adverse clinical reactions which persist longer may be associated with intolerance to a wide range of foods. Children with persistent CMA frequently develop eczema, asthma and rhinitis. Because of these complexities children with CMA should remain under the long term care of a medical practitioner familiar with the management of these problems. Medical practitioners responsible for the care of children with suspected CMA must be prepared to conduct cow milk challenges in a safe environment with facilities for resuscitation available. The notion that infants with suspected CMA should be referred to nutritionists and health workers for implementation of empirically devised low allergen diet programs without the diagnosis of CMA, being firmly established should be rejected. Where the diagnosis of CMA has not been made with certainty, parents may resort to unreasonable dietary restrictions.

Entities:  

Mesh:

Year:  1995        PMID: 8647057

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

1.  Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy.

Authors:  Scott H Sicherer; Robert A Wood; Donald Stablein; A Wesley Burks; Andrew H Liu; Stacie M Jones; David M Fleischer; Donald Y M Leung; Alexander Grishin; Lloyd Mayer; Wayne Shreffler; Robert Lindblad; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

2.  Clinical factors associated with peanut allergy in a high-risk infant cohort.

Authors:  Scott H Sicherer; Robert A Wood; Tamara T Perry; Stacie M Jones; Donald Y M Leung; Alice K Henning; Peter Dawson; A Wesley Burks; Robert Lindblad; Hugh A Sampson
Journal:  Allergy       Date:  2019-07-15       Impact factor: 13.146

3.  The content of docosahexaenoic acid in the maternal diet differentially affects the immune response in lactating dams and suckled offspring.

Authors:  Caroline Richard; Erin D Lewis; Susan Goruk; Catherine J Field
Journal:  Eur J Nutr       Date:  2015-09-10       Impact factor: 5.614

4.  Anxiety-like behavior and intestinal microbiota changes as strain-and sex-dependent sequelae of mild food allergy in mouse models of cow's milk allergy.

Authors:  Nicholas A Smith; Danielle L Germundson; Pan Gao; Junguk Hur; Angela M Floden; Kumi Nagamoto-Combs
Journal:  Brain Behav Immun       Date:  2021-03-09       Impact factor: 19.227

5.  Cow's Milk Protein Allergy from Diagnosis to Management: A Very Different Journey for General Practitioners and Parents.

Authors:  Adriana C Lozinsky; Rosan Meyer; Katherine Anagnostou; Robert Dziubak; Kate Reeve; Heather Godwin; Adam T Fox; Neil Shah
Journal:  Children (Basel)       Date:  2015-07-21

Review 6.  Hydrolyzed Rice Formula: An Appropriate Choice for the Treatment of Cow's Milk Allergy.

Authors:  Caterina Anania; Ivana Martinelli; Giulia Brindisi; Daniela De Canditiis; Giovanna De Castro; Anna Maria Zicari; Francesca Olivero
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.